• Member, Dean’s Advisory Council, University at Buffalo School of Law
• Member, Committee on Mergers and Acquisitions and Corporate Control Contests, New York City Bar Association

• Recommended for M&A/Corporate in the 2026 edition of Legal 500
• Recognized as “Highly Regarded” for M&A in the U.S. in the 2026 edition of IFLR1000
• Named to Lawdragon’s 2024 “500 X – The Next Generation” list
• Named among Law360’s 2017 “Rising Stars” for M&A
• Honored among M&A Advisor’s 2017 “Emerging Leaders”
• Named a 2013-2017 “Rising Star” for M&A by Super Lawyers

Select Matters

Select representations include:

• The Dow Chemical Company in its $130 billion all-stock merger of equals with E. I. du Pont de Nemours and Company*
• Kinder Morgan in its $76 billion acquisition of all the outstanding equity securities of Kinder Morgan Energy Partners, Kinder Morgan Management, and El Paso Pipeline Partners*
• DIRECTV in its $67.1 billion sale to AT&T*
• Dow in its approximately $40 billion spin-off from DowDuPont Inc. as part of DowDuPont's separation into three independent, publicly traded companies*
• Kinder Morgan in its $38 billion acquisition of El Paso Corporation*
• DIRECTV in its $28.5 billion stock-for-stock merger with Liberty Entertainment*
• The Kroger Company in its proposed $24.6 billion merger with Albertsons Companies, Inc., and in the approximately $1.9 billion sale of 413 stores, as well as select banners, distribution centers, offices, and private-label brands, to C&S Wholesale Grocers, LLC*
• MGM Resorts International in its $17.2 billion sale of MGM Growth Properties LLC to VICI Properties Inc.*
• Intel Corporation in its $16.7 billion acquisition of Altera Corporation*
• JAB Holding Company, as leader of an investment group, in that group's $13.9 billion take-private of Keurig Green Mountain, Inc.*
• Sanofi in its $11.6 billion acquisition of Bioverativ Inc. and its $9.5 billion acquisition of Blueprint Medicines*
• Apergy Corporation (n/k/a ChampionX Corporation) in a Reverse Morris Trust acquisition of ChampionX (f/k/a Nalco Champion) from Ecolab Inc., creating an entity with a combined $7.4 billion enterprise value*
• Sunoco LP in its approximately $7.3 billion acquisition of NuStar Energy L.P.*
• Legg Mason, Inc., in its $6.5 billion sale to Franklin Templeton Investments*
• athenahealth, Inc. in its evaluation of an unsolicited takeover bid by Elliott Management Corporation and subsequent $5.7 billion sale to Veritas Capital and Evergreen Coast Capital (an affiliate of Elliott Management Corporation) and planned combination with Virence Health*
• Kinder Morgan Energy Partners, L.P. in its $5 billion acquisition of Copano Energy LLC*
• inVentiv Health, Inc. in its $4.6 billion merger with INC Research Holdings, Inc., creating Syneos Health, Inc.*
• Lincare Holdings Inc. in its $4.6 billion acquisition by Linde Group*
• Media General Inc. in its $4.6 billion sale to Nexstar Broadcasting Group Inc.*
• Thomas H. Lee Partners (THL) and inVentiv Health, Inc. (n/k/a Syneos Health, Inc.) in THL’s sale of a 50 percent interest in inVentiv to Advent International, valuing inVentiv at $3.8 billion*
• Sanofi in its $3.7 billion acquisition of Principia Biopharma Inc.*
• Belmond Ltd. in its $3.2 billion sale to LVMH Moet Hennessy Louis Vuitton SE*
• Sanofi SA in its acquisition of Provention Bio Inc. (PRVB) for $2.9 billion in cash*
• Front Yard Residential Corporation in its $2.5 billion take-private by a partnership formed by Pretium Partners and Ares Management*
• Sanofi in its $2.2 billion acquisition of Dynavax*
• Nexeo Solutions, Inc., in its $2 billion sale to Univar Inc.*
• Dycom Industries in its $1.95 billion acquisition of Power Solutions*
• Black Knight, Inc. in its acquisition of Optimal Blue LLC, in a transaction that implied an enterprise value of $1.8 billion and subsequently a Special Committee of Black Knight in the $1.2 billion acquisition of all the equity interests Black Knight did not already own in Optimal Blue*
• MGM Resorts International in its $1.625 billion acquisition of the operations of The Cosmopolitan of Las Vegas*
• MGM Resorts International in its $1.175 billion sale of the real property of the Borgata Hotel Casino & Spa in Atlantic City, New Jersey, to MGM Growth Properties LLC*
• MGM Resorts International in its $1.075 billion sale of the operations of The Mirage Hotel & Casino on the Las Vegas Strip to Hard Rock International*
• Halozyme Therapeutics, Inc. in its $960 million acquisition of Antares Pharma, Inc.*
• Halozyme Therapeutics, Inc. in its $900 million acquisition of Elektrofi*
• Sanofi in its up to $470 million acquisition of Tidal Therapeutics, Inc.*
• Halozyme Therapeutics, Inc., in its $400 million acquisition of Surf Bio, Inc.*

*Denotes matters handled at another firm prior to joining Wilson Sonsini in 2026.